Answers are grounded in this paper and cite their sources.
Neuroinflammation contributes to pathogenesis across Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, ischemic stroke, and primary brain tumors, but single-cell and spatial transcriptomic atlases of these conditions have largely been analyzed in isolation, obscuring how these conditions engage shared versus disease-specific immunological programs. This review examines how computational frameworks for single-cell and spatial multi-omics analysis can identify shared and disease-specific neuroimmune patterns across brain disorders. Organized by analytical paradigm rather than by individual disease, the review covers data integration and cell-state annotation, trajectory inference, gene regulatory network reconstruction, spatial deconvolution, GWAS-to-cell-type mapping, and intercellular communication, drawing on cross-disease evidence from Alzheimer’s disease, glioma, multiple sclerosis, Parkinson’s disease, and stroke. The evidence identifies four neuroinflammatory modules that recur across diagnostic boundaries, including disease-associated microglia (DAM) activation, interferon-stimulated gene responses, complement cascade reactivation, and metabolic reprogramming toward glycolysis. Despite this shared core, the tissue-level manifestation of these modules differs substantially across conditions, and the spatial architecture of immune cell organization is disease-specific. Translation of these findings is constrained by nomenclature fragmentation across independently defined microglial states, species discordance between mouse models and human tissue, underrepresentation of non-Alzheimer’s neurodegenerative and psychiatric disorders, and the near-complete absence of prospective clinical validation for computationally defined cell states. Addressing these gaps requires the field to advance from cataloguing cell states to cross-disease integrative frameworks with unified cell-state nomenclature, prospective validation in clinical cohorts, and analytical methods capable of distinguishing correlation from causation in neuroimmune cascades. This review provides a comparative framework for interpreting neuroimmune cell states across brain disorders and delineates the analytical and translational priorities most likely to advance mechanism-based therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: